[go: up one dir, main page]

SK53696A3 - Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use - Google Patents

Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use Download PDF

Info

Publication number
SK53696A3
SK53696A3 SK536-96A SK53696A SK53696A3 SK 53696 A3 SK53696 A3 SK 53696A3 SK 53696 A SK53696 A SK 53696A SK 53696 A3 SK53696 A3 SK 53696A3
Authority
SK
Slovakia
Prior art keywords
preparation
group
optionally substituted
carbapenem
methyl
Prior art date
Application number
SK536-96A
Other languages
English (en)
Slovak (sk)
Inventor
Steven Coulton
Jeremy David Hinks
Eric Hunt
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939322284A external-priority patent/GB9322284D0/en
Priority claimed from GB9410929A external-priority patent/GB9410929D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK53696A3 publication Critical patent/SK53696A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK536-96A 1993-10-29 1994-10-25 Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use SK53696A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939322284A GB9322284D0 (en) 1993-10-29 1993-10-29 Novel compounds
GB9410929A GB9410929D0 (en) 1994-06-01 1994-06-01 Novel compounds
PCT/GB1994/002347 WO1995011905A1 (fr) 1993-10-29 1994-10-25 Derives de 2-(pyrazol-3-yle)carbapenem

Publications (1)

Publication Number Publication Date
SK53696A3 true SK53696A3 (en) 1996-10-02

Family

ID=26303758

Family Applications (1)

Application Number Title Priority Date Filing Date
SK536-96A SK53696A3 (en) 1993-10-29 1994-10-25 Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use

Country Status (22)

Country Link
US (1) US5612477A (fr)
EP (1) EP0725783B1 (fr)
JP (1) JP3703146B2 (fr)
KR (1) KR960705827A (fr)
CN (1) CN1167486A (fr)
AP (1) AP9600800A0 (fr)
AT (1) ATE229957T1 (fr)
AU (1) AU697108B2 (fr)
BG (1) BG100551A (fr)
BR (1) BR9407889A (fr)
CA (1) CA2175054C (fr)
CZ (1) CZ122996A3 (fr)
DE (1) DE69431919T2 (fr)
ES (1) ES2188621T3 (fr)
FI (1) FI961817A7 (fr)
HU (1) HUT75519A (fr)
NO (1) NO961654L (fr)
NZ (1) NZ274878A (fr)
OA (1) OA10287A (fr)
PL (1) PL314173A1 (fr)
SK (1) SK53696A3 (fr)
WO (1) WO1995011905A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020147333A1 (en) 1993-10-29 2002-10-10 Smithkline Beecham P.L.C. 2-(pyrazol-3-yl)carbapenem derivatives
EP0785937A1 (fr) * 1994-10-14 1997-07-30 Smithkline Beecham Plc Derives de 2-(imidazol-4-yl)carbapeneme, leurs intermediaires ainsi que leur utilisation en tant qu'antibacteriens
IL118092A0 (en) * 1995-05-03 1996-09-12 Smithkline Beecham Plc Antibacterial compounds their preparation and pharmaceutical compositions containing them
KR19990008354A (ko) * 1995-05-03 1999-01-25 페터 죤 기딩스 카르바페넴의 에스테르
GB0400329D0 (en) * 2004-01-08 2004-02-11 Glaxo Group Ltd Novel processes
GB0400405D0 (en) * 2004-01-09 2004-02-11 Glaxo Group Ltd Novel processes
JP2007039383A (ja) * 2005-08-03 2007-02-15 Dainippon Sumitomo Pharma Co Ltd アリールカルバペネム化合物の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
EP0430037A3 (en) * 1989-11-21 1992-05-27 Banyu Pharmaceutical Co., Ltd. Process for producing 2-carbon-substituted carbapenem derivatives
CA2036960A1 (fr) * 1990-02-26 1991-08-27 Thomas A. Rano Nouvelle synthese de produits intermediaires des carbapenemes
JP3233434B2 (ja) * 1992-04-01 2001-11-26 塩野義製薬株式会社 カルバペネム誘導体

Also Published As

Publication number Publication date
HUT75519A (en) 1997-05-28
CN1167486A (zh) 1997-12-10
AP9600800A0 (en) 1996-04-30
EP0725783B1 (fr) 2002-12-18
BR9407889A (pt) 1996-10-29
KR960705827A (ko) 1996-11-08
NO961654L (no) 1996-06-11
BG100551A (bg) 1997-01-31
CA2175054A1 (fr) 1995-05-04
ATE229957T1 (de) 2003-01-15
OA10287A (en) 1997-10-07
WO1995011905A1 (fr) 1995-05-04
FI961817L (fi) 1996-06-28
FI961817A7 (fi) 1996-06-28
AU7997594A (en) 1995-05-22
HU9601097D0 (en) 1996-07-29
PL314173A1 (en) 1996-08-19
CA2175054C (fr) 2005-07-12
ES2188621T3 (es) 2003-07-01
AU697108B2 (en) 1998-09-24
DE69431919T2 (de) 2003-11-13
EP0725783A1 (fr) 1996-08-14
FI961817A0 (fi) 1996-04-29
NZ274878A (en) 1998-02-26
DE69431919D1 (de) 2003-01-30
JPH09504285A (ja) 1997-04-28
NO961654D0 (no) 1996-04-25
JP3703146B2 (ja) 2005-10-05
US5612477A (en) 1997-03-18
CZ122996A3 (en) 1996-10-16

Similar Documents

Publication Publication Date Title
US5004739A (en) 2-phenanthrenyl carbapenem antibacterial agents
SK53696A3 (en) Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use
NZ525934A (en) 1-methylcarbapenem derivatives
JPH10507185A (ja) ２−（イミダゾール−４−イル）カルバペネム誘導体、その中間体および抗菌剤としての使用
US5606051A (en) 2-(pyrazol-3-yl)carbapenem derivatives
US7045619B2 (en) 2-(pyrazol-3-yl)carbapenem derivatives
US5132420A (en) Intermediates for preparing 2-(substituted-dibenzo-furanyl and dibenzothienyl) carbapenem antibacterial agents
MXPA97008422A (en) Carbapene steres
KR19990008354A (ko) 카르바페넴의 에스테르
EP0823910A1 (fr) Ester de carbapenems
JPH0788384B2 (ja) ２−フェナンスリドニル カルバペネム類
JP2004043438A (ja) １−メチルカルバペネム誘導体を含有する医薬
JPH0613517B2 (ja) ２−アザ置換１−カルバデチアペン−２−エム−３−カルボン酸
MXPA97008421A (en) Carbapene steres
CA2331586A1 (fr) Nouveaux composes .beta.-lactam et leur procede de preparation
JPWO1999058536A1 (ja) 新規なβ−ラクタム化合物およびその製造法
MXPA01000611A (en) Novel carbapenem derivatives